CLEC7A and tinea unguium: For example, a few DECTIN-1–deficient patients who carry the p.Y238* CLEC7A mutation in homozygosity [126], which abolishes DECTIN-1–dependent signaling, were reported to develop recurrent VVC (RVVC) and onychomycosis.